This deeply trusted maternal wellness supplement brand focuses on premium, research-backed dietary supplements for women across fertility, pregnancy, postpartum, and long-term wellness stages. Growth has been suppressed by cross-border logistics and capital constraints rather than market demand. With Amazon listings approved and ready to activate for both Canada and the US, retail partnerships just launched, new products ready for release (including a customer-requested DHA supplement launching soon), and momentum building in US expansion, the business presents multiple ready-to-execute growth levers across underutilized channels.

Products are manufactured in a GMP-compliant, NSF-certified, FDA-registered facility and undergo triple-testing by independent labs. This commitment to quality has earned the brand 4.8- to 4.9-star average ratings, a 72% returning customer rate, and a product return rate of only 1.4%.

Limited working capital caused inventory stockouts that hampered retention, prevented a proper Amazon launch, and forced a reduction in US advertising. US sales have recently declined from 33% to 21% of revenue due to cross-border delays, but Canadian performance demonstrates strong product-market fit. For a well-capitalized buyer, these constraints represent immediate opportunities.

The business requires minimal founder involvement at 5–10 hours per week, with an experienced team managing day-to-day operations. The current owner does not have the capital needed for continued growth and is also expecting soon, so she wants to sell in order to provide some financial stability and focus on her growing family instead of the business.


Key Benefits:

High Monthly Recurring Revenue: More than 60% of total revenue comes from over 3,300 subscriptions and a subscriber AOV of $63–$66, creating predictable cash flow and high customer retention.

Lifetime Value of $237: A product return rate of only 1.4% demonstrates strong customer satisfaction, with customers consistently reporting improved energy, better mood, and appreciation for clean ingredients through daily positive feedback.

Amazon Listings Approved and Ready: Seller accounts and listings are fully configured for both Canadian and US markets, with a reputable agency lined up to support launch, requiring only inventory allocation to activate.

New Products Ready for Immediate Launch: A customer-requested DHA supplement launching in February 2026, Her Daily+ in the NPN approval process for spring 2026, and three additional formulas with NPNs are included in the sale.

$1.4B US Maternal Supplement Market: The US maternal health market is 10 times larger than Canada, with demand already validated but currently constrained by cross-border logistics that US-based manufacturing would eliminate, unlocking demand.

Turnkey Operations: With an experienced team managing day-to-day operations, a fractional CFO/COO onboarded, and team capacity to support 1.75x–2x current revenue without additional hiring, a new owner is able to focus on strategic growth.